“Prostate cancer is the first cancer to have an AI biomarker to help make decisions in a cancer patient. It's not taking-over-the-world type AI. It's helping you live longer and better.”

And of course, none of us actually knows how many more years we have to live. But if we expect to live at least 10 years, we could do the screening and get some benefit from it.

…a little bit about AI, because artificial intelligence is like taking over everything. And I talk to radiologists on a regular basis and they say, yeah, we are using AI sort of as a double check or a verification. What about when it comes to breast cancer and prostate cancer? Is AI playing a role?

I would like to ask, right while we're here, while you've just talked about it, when you say hormonal therapy, what do you mean?

It's a great question, Terry. It's actually anti-hormonal therapy when we talk about these cancers because prostate cancer is driven by the male hormone, testosterone, breast cancer often driven by the female hormone, estrogen or progesterone. And so when we're talking about hormonal therapy, we're…

So anti-androgens for men, that is to say, blocking testosterone or preventing its formation. What about in women? We hear a lot about anti-estrogens, especially after surgery.